Combination treatment in the presence of chronic HFHS feeding prevented adipose tissue mass gain and inhibited the development of obesity, exerted a robust effect on brain insulin sensitivity, and decreased the deposition of protein levels of Aβ, detected by the antibody 4G8. The gene discussed is INS; the disease is obesity disorder.